Knowledge Mapping and Research Hotspots of Comorbidities in Psoriasis: A Bibliometric Analysis from 2004 to 2022

• Published in: Medicina (Kaunas, Lithuania) Vol. 59; no. 2; p. 393
• Main Authors: Huang, Shan, Bai, Yanping
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 17-02-2023; MDPI
• Subjects: Arthritis, Psoriatic; Bibliometrics; Citation analysis; Cluster analysis; Clustering; Cocitation; Collaboration; Comorbidity; Complications and side effects; Cooperation; Data analysis; Diagnosis; Disease; Drug therapy; Epidemiology; Humans; Knowledge; Metabolic syndrome; Psoriasis; Psoriatic arthritis; research hotspots; Risk factors; Skin; Software; Systematic review; Trends; Visualization; visualization analysis; China; Italy; California; United States > US; Germany; research hotspots; comorbidity; visualization analysis; bibliometrics; psoriasis
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina59020393

: Psoriasis is a chronic inflammatory disease whose impact on health is not only limited to the skin, but is also associated with multiple comorbidities. Early screening for comorbidities along with appropriate treatment plans can provide a positive prognosis for patients. This study aimed to summarize the knowledge structure in the field of psoriasis comorbidities and further explore its research hotspots and trends through bibliometrics.
: A search was conducted in the core collection of the Web of Science for literature on comorbidities of psoriasis from 2004 to 2022. VOSviewer and CiteSpace software were used for collaborative network analysis, co-citation analysis of references, and keyword co-occurrence analysis on these publications.
: A total of 1803 papers written by 6741 authors from 81 countries was included. The publications have shown a progressive increase since 2004. The United States and Europe were at the forefront of this field. The most prolific institution was the University of California, and the most productive author was A. Armstrong. Research has focused on "psoriatic arthritis", "metabolic syndrome", "cardiovascular disease", "psychosomatic disease", "inflammatory bowel disease", "prevalence", "quality of life", and "risk factor" in the past 18 years. Keywords such as "biologics" and "systemic inflammation", have been widely used recently, suggesting current research hotspots and trends.
: Over the past 18 years, tremendous progress has been made in research on psoriasis comorbidity. However, collaborations among countries, institutions, and investigators are inadequate, and the study of the mechanisms of interaction between psoriasis and comorbidities and management of comorbidities is insufficient. The treatment of comorbidities with biologic agents, screening of comorbidities, and multidisciplinary co-management are predicted to be the focus of future research.